Sharon Marsh

Sharon Marsh

UNVERIFIED PROFILE

Are you Sharon Marsh?   Register this Author

Register author
Sharon Marsh

Sharon Marsh

Publications by authors named "Sharon Marsh"

Are you Sharon Marsh?   Register this Author

89Publications

-Reads

Validation of microRNA pathway polymorphisms in esophageal adenocarcinoma survival.

Cancer Med 2017 Feb 11;6(2):361-373. Epub 2017 Jan 11.

Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada.

View Article
February 2017

The Pathogenesis of Nonalcoholic Fatty Liver Disease: Interplay between Diet, Gut Microbiota, and Genetic Background.

Gastroenterol Res Pract 2016 9;2016:2862173. Epub 2016 May 9.

Department of Nutrition and Food Science, Texas A&M University, Houston, TX 77843, USA.

View Article
June 2016

Gut Microbiota and Metagenomic Advancement in Digestive Disease.

Gastroenterol Res Pract 2016 10;2016:4703406. Epub 2016 May 10.

Department of Nutrition and Food Science, Texas A&M University, Houston, TX 77843, USA.

View Article
June 2016

Pharmacogenomic assessment of Mexican and Peruvian populations.

Pharmacogenomics 2015 ;16(5):441-8

Faculty of Pharmacy & Pharmaceutical Sciences, 3142F Katz Centre for Pharmacy & Health Research, University of Alberta, Edmonton, AB T6G 2E1, Canada.

View Article
January 2016

eHealth: past and future perspectives.

Per Med 2016 Jan 6;13(1):57-70. Epub 2016 Jan 6.

Faculty of Pharmacy & Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada.

View Article
January 2016

A Bridging Opportunities Work-frame to develop mobile applications for clinical decision making.

Future Sci OA 2015 Nov 1;1(3):FSO8. Epub 2015 Nov 1.

Faculty of Pharmacy & Pharmaceutical Sciences, 3142, Katz Group Centre for Pharmacy & Health Research, University of Alberta, Edmonton, Alberta, AB T6G 2E1, Canada; Faculty of Pharmacy & Pharmaceutical Sciences, 3142, Katz Group Centre for Pharmacy & Health Research, University of Alberta, Edmonton, Alberta, AB T6G 2E1, Canada.

View Article
November 2015

Discovery and validation of vascular endothelial growth factor (VEGF) pathway polymorphisms in esophageal adenocarcinoma outcome.

Carcinogenesis 2015 Sep 25;36(9):956-62. Epub 2015 May 25.

Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre and University of Toronto, 610 University Ave, Toronto, Ontario M5G 2M9, Canada.

View Article
September 2015

AntiC: A practice tool for the safe use of oral chemotherapeutics by community and hospital pharmacists.

Can Pharm J (Ott) 2015 May;148(3):118-24

Faculty of Pharmacy and Pharmaceutical Sciences (van Rooij, Rix, Marsh), University of Alberta, Edmonton.

View Article
May 2015

Fast and frugal trees: translating population-based pharmacogenomics to medication prioritization.

Per Med 2015 Mar;12(2):117-128

Faculty of Pharmacy & Pharmaceutical Sciences, Katz Group Centre for Pharmacy & Health Research, University of Alberta, Edmonton, Alberta T6G 2E1, Canada.

View Article
March 2015

Pyrosequencing of clinically relevant polymorphisms.

Methods Mol Biol 2013 ;1015:97-114

Department of Internal Medicine, Washington University in St. Louis, St. Louis, MO, USA.

View Article
February 2014

Pharmacogenomics of third-generation aromatase inhibitors.

Expert Opin Pharmacother 2012 Jun 17;13(9):1299-307. Epub 2012 May 17.

University of Alberta, Faculty of Pharmacy and Pharmaceutical Sciences, 3142F Katz Group Centre for Pharmacy and Health Research, Edmonton, AB T6G 2E1, Canada.

View Article
June 2012

Personalized medicine policy challenges: measuring clinical utility at point of care.

Expert Rev Pharmacoecon Outcomes Res 2012 Jun;12(3):289-95

Faculty of Pharmacy and Pharmaceutical Sciences, 3142L, Katz Group Centre for Pharmacy & Health Research, University of Alberta, 11361-87 Avenue, Edmonton, AB T6G 2E1, Canada.

View Article
June 2012

Identification of novel markers for 5-FU and FOLFOX toxicity.

Authors:
Sharon Marsh

Pharmacogenomics 2012 May;13(7):744-5

Faculty of Pharmacy & Pharmaceutical Sciences, 3142F Katz Group Centre for Pharmacy & Health Research, University of Alberta, Edmonton, AB, T6G 2E1, Canada.

View Article
May 2012

CD133 as a marker of response to bevacizumab.

Authors:
Sharon Marsh

Pharmacogenomics 2012 May;13(7):745

Faculty of Pharmacy & Pharmaceutical Sciences, 3142F Katz Group Centre for Pharmacy & Health Research, University of Alberta, Edmonton, AB, T6G 2E1, Canada.

View Article
May 2012

EGFR R521K predicts cetuximab response in KRAS wild-type patients.

Authors:
Sharon Marsh

Pharmacogenomics 2012 May;13(7):746

Faculty of Pharmacy & Pharmaceutical Sciences, 3142F Katz Group Centre for Pharmacy & Health Research, University of Alberta, Edmonton, AB, T6G 2E1, Canada.

View Article
May 2012

Genetic polymorphisms as predictive and prognostic biomarkers in gynecological cancers: a systematic review.

Gynecol Oncol 2012 Feb 6;124(2):354-65. Epub 2011 Nov 6.

Division of Medical Oncology, Princess Margaret Hospital, University of Toronto, Ontario, Canada.

View Article
February 2012

Doxorubicin pathways: pharmacodynamics and adverse effects.

Pharmacogenet Genomics 2011 Jul;21(7):440-6

Departments of Genetics, Stanford University Medical Center, California 94305-5120, USA.

View Article
July 2011

The NQO1*2/*2 polymorphism is associated with poor overall survival in patients following resection of stages II and IIIa non-small cell lung cancer.

Oncol Rep 2011 Jun 6;25(6):1765-72. Epub 2011 Apr 6.

School of Pharmacy, University of Wisconsin Paul P Carbone Comprehensive Cancer Center, University of Wisconsin, Madison, WI 53792-5669, USA.

View Article
June 2011

Improving oncology outcomes through targeted therapeutics will require electronic delivery systems.

Future Oncol 2011 May;7(5):649-56

Faculty of Pharmacy & Pharmaceutical Sciences, 3126 Dentistry/Pharmacy Centre, University of Alberta, Edmonton, AB T6G 2N8, Canada.

View Article
May 2011

PharmGKB summary: fluoropyrimidine pathways.

Pharmacogenet Genomics 2011 Apr;21(4):237-42

Department of Genetics, Stanford University Medical Center, Stanford, California, USA.

View Article
April 2011

Damming the genomic data flood using a comprehensive analysis and storage data structure.

Database (Oxford) 2010 15;2010:baq029. Epub 2010 Dec 15.

Beaulieu-Saucier Université de Montréal Pharmacogenomics Centre, Université de Montréal, Quebec, Canada.

View Article
March 2011

Irinotecan pharmacogenomics.

Pharmacogenomics 2010 Jul;11(7):1003-10

UNC Institute for Pharmacogenomics & Individualized Therapy, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.

View Article
July 2010

Cytochrome P450 2C9-CYP2C9.

Pharmacogenet Genomics 2010 Apr;20(4):277-81

Center for Pharmacogenomics at Washington University, St Louis, Missouri, USA.

View Article
April 2010

Integrating genomic-based clinical decision support into electronic health records.

Per Med 2010 Mar;7(2):163-170

Génome Québec & Montreal Heart Institute Pharmacogenomics Centre, 5000 rue Belanger, Montreal, Quebec H1T 1C8, Canada.

View Article
March 2010

Pharmacogenomics of taxane/platinum therapy in ovarian cancer.

Authors:
Sharon Marsh

Int J Gynecol Cancer 2009 Dec;19 Suppl 2:S30-4

Génome Québec and Montreal Heart Institute Pharmacogenomics Centre, 5000 rue Bélanger, Montreal, Quebec, Canada.

View Article
December 2009

Taxane pathway.

Pharmacogenet Genomics 2009 Dec;19(12):979-83

Genome Quebec and Montreal Heart Institute Pharmacogenomics Centre, Montreal, Quebec, Canada.

View Article
December 2009

Challenges of incorporating pharmacogenomics into clinical practice.

Gastrointest Cancer Res 2009 Sep;3(5):206-7

Génome Québec and Montreal Heart Institute, Pharmacogenomics Centre, Montreal, Quebec, Canada.

View Article
September 2009

Platinum pathway.

Pharmacogenet Genomics 2009 Jul;19(7):563-4

Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.

View Article
July 2009

Pharmacokinetics and pharmacogenomics in breast cancer chemotherapy.

Adv Drug Deliv Rev 2009 May 3;61(5):381-7. Epub 2008 Dec 3.

Genome Quebec and Montreal Heart Institute Pharmacogenomics Centre, Montreal, Quebec, Canada.

View Article
May 2009

Association of thymidylate synthase variants with 5-fluorouracil cytotoxicity.

Pharmacogenet Genomics 2009 May;19(5):399-401

Schools of Pharmacy and Medicine, University of North Carolina, Chapel Hill, North Carolina, USA.

View Article
May 2009

DNA methylotype analysis in colorectal cancer.

Oncol Rep 2008 Oct;20(4):921-7

Department of Medicine, Washington University School of Medicine, Saint Louis, MO 63110, USA.

View Article
October 2008

Génome Québec & Montreal Heart Institute Pharmacogenomics Centre: a translational pharmacogenomics platform--from R&D to the clinic.

Pharmacogenomics 2008 Oct;9(10):1391-6

Génome Québec and Montreal Heart Institute Pharmacogenomics Centre, 5000 Bélanger E, Montreal, Quebec H1T1C8, Canada.

View Article
October 2008

Interaction between PPARA genotype and beta-blocker treatment influences clinical outcomes following acute coronary syndromes.

Pharmacogenomics 2008 Oct;9(10):1403-17

Department of Medicine, Washington University School of Medicine, 660 South Euclid Avenue, Campus Box 8086, Saint Louis, MO 63110-1093, USA.

View Article
October 2008

Cancer pharmacogenetics.

Authors:
Sharon Marsh

Methods Mol Biol 2008 ;448:437-46

Division of Oncology, Washington University School of Medicine, St. Louis, Missouri, USA.

View Article
May 2008

Pharmacogenetics: global clinical markers.

Authors:
Sharon Marsh

Pharmacogenomics 2008 Apr;9(4):371-3

View Article
April 2008

Irinotecan pharmacogenetics: influence of pharmacodynamic genes.

Clin Cancer Res 2008 Mar;14(6):1788-96

Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.

View Article
March 2008

Integrating pharmacogenomics into oncology clinical practice.

Expert Rev Clin Pharmacol 2008 Jan;1(1):73-80

Washington University in St Louis, Division of Oncology, 660 South Euclid Ave - Campus Box 8069, St Louis, MO 63110, USA.

View Article
January 2008

Connexin37 (GJA4) genotype predicts survival after an acute coronary syndrome.

Am Heart J 2007 Sep;154(3):561-6

Henry Ford Heart and Vascular Institute and Wayne State University, Detroit, MI, USA.

View Article
September 2007

Pyrosequencing applications.

Authors:
Sharon Marsh

Methods Mol Biol 2007 ;373:15-24

Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA.

View Article
June 2007

Impact of pharmacogenomics on clinical practice in oncology.

Authors:
Sharon Marsh

Mol Diagn Ther 2007 ;11(2):79-82

Division of Oncology, Washington University School of Medicine, St Louis, Missouri 63110, USA.

View Article
June 2007

Identification of NR1I2 genetic variation using resequencing.

Eur J Clin Pharmacol 2007 Jun 3;63(6):547-54. Epub 2007 Apr 3.

Department of Medicine, Washington University School of Medicine, St. Louis, MO, 63110, USA.

View Article
June 2007

Pharmacogenetics and oncology treatment for breast cancer.

Expert Opin Pharmacother 2007 Feb;8(2):119-27

Washington University School of Medicine, Division of Oncology, St Louis, MO 63110, USA.

View Article
February 2007

Genetic variation in the B-type natiuretic peptide pathway affects BNP levels.

Cardiovasc Drugs Ther 2007 Feb 3;21(1):55-62. Epub 2007 Mar 3.

Section of Advanced Heart Failure and Cardiac Transplantation, Henry Ford Heart and Vascular Institute, Henry Ford Hospital, 2799 W. Grand Boulevard, Cardiology K14, Detroit, MI 48202, USA.

View Article
February 2007

A phase II study of irinotecan and carboplatin in advanced non-small cell lung cancer with pharmacogenomic analysis: final report.

J Thorac Oncol 2006 Nov;1(9):972-8

Division of Medical Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 63110, USA.

View Article
November 2006

Disposition of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite in relation to ABC transporter genotypes.

Invest New Drugs 2006 Sep;24(5):393-401

Hillman Cancer Research Center, Molecular Therapeutics Drug Discovery Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USA.

View Article
September 2006

DNA repair pathway profiling and microsatellite instability in colorectal cancer.

Clin Cancer Res 2006 Sep;12(17):5104-11

Department of Medicine, Washington University School of Medicine and Siteman Cancer Center, Saint Louis, Missouri 63110-1093, USA.

View Article
September 2006

Global pharmacogenetics: giving the genome to the masses.

Pharmacogenomics 2006 Jun;7(4):625-31

Washington University School of Medicine, Department of Medicine, Room 1021 CSRB NT, 660 South Euclid Avenue, Campus Box 8069, St Louis, MO 63110, USA.

View Article
June 2006

Pharmacogenomics: from bedside to clinical practice.

Hum Mol Genet 2006 Apr;15 Spec No 1:R89-93

Division of Oncology, Washington University School of Medicine, St Louis, MO 63110, USA.

View Article
April 2006

Systems pharmacogenomics in yeast.

Pharmacogenomics 2006 Mar;7(2):255-9

Washington University School of Medicine, Department of Medicine, Division of Oncology, Computational Biology Program, St Louis, Missouri 63110, USA.

View Article
March 2006

Taxane pharmacogenetics.

Authors:
Sharon Marsh

Per Med 2006 Feb;3(1):33-43

Washington University School of Medicine, Division of Oncology, 660 South Euclid Ave - Campus Box 8069, St Louis, MO 63110, USA.

View Article
February 2006

Polymorphism discovery in 51 chemotherapy pathway genes.

Hum Mol Genet 2005 Dec 20;14(23):3595-603. Epub 2005 Oct 20.

Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.

View Article
December 2005

Thymidylate synthase pharmacogenetics.

Authors:
Sharon Marsh

Invest New Drugs 2005 Dec;23(6):533-7

Division of Molecular Oncology, Washington University School of Medicine in St. Louis, 660, South Euclid Avenue, Campus Box 8069, St. Louis, MO 63110, USA.

View Article
December 2005

Concordance of pharmacogenetic markers in germline and colorectal tumor DNA.

Pharmacogenomics 2005 Dec;6(8):873-7

Washington University School of Medicine, Campus Box 8069-660 South Euclid AvenueSt Louis, MO 63110, USA.

View Article
December 2005

Pharmacogenetics of colorectal cancer.

Authors:
Sharon Marsh

Expert Opin Pharmacother 2005 Dec;6(15):2607-16

Division of Oncology, Washington University School of Medicine, 660 South Euclid Ave, Campus Box 8069, St Louis, MO 63110, USA.

View Article
December 2005

Pyrosequencing of clinically relevant polymorphisms.

Methods Mol Biol 2005 ;311:97-114

Division of Molecular Oncology, Washington University School of Medicine, St. Louis, MO, USA.

View Article
November 2005

CpG island methylation of DNA damage response genes in advanced ovarian cancer.

Cancer Res 2005 Oct;65(19):8961-7

Centre for Oncology and Applied Pharmacology, Cancer Research UK Beatson Laboratories, University of Glasgow, Glasgow, United Kingdom.

View Article
October 2005

Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome.

JAMA 2005 Sep;294(12):1526-33

Departments of Medicine, Genetics, and Molecular Biology and Pharmacology, Washington University School of Medicine, St Louis, Mo;

View Article
September 2005

Pharmacogenetics goes 3D.

Nat Genet 2005 Aug;37(8):794-5

View Article
August 2005

CYP3A4 and CYP3A5 genotyping by Pyrosequencing.

BMC Med Genet 2005 May 9;6:19. Epub 2005 May 9.

Washington University School of Medicine, Department of Medicine, Division of Oncology, St. Louis, MO 63110, USA.

View Article
May 2005

Role of Pharmacogenetics in Rational Development and Personalization of Drug Treatments.

Authors:
Sharon Marsh

Per Med 2005 Mar;2(1):13-14

Washington University School of Medicine , Division of Oncology, 660 South Euclid Ave. - Campus Box 8069, St Louis, MO 63110 , USA Tel; Fax; E-mail:

View Article
March 2005

Distribution of ITPA P32T alleles in multiple world populations.

J Hum Genet 2004 21;49(10):579-81. Epub 2004 Aug 21.

Division of Oncology, Washington University School of Medicine, 660 South Euclid Avenue, Campus Box 8069, St Louis, MO 63110, USA.

View Article
January 2005

CEPH individuals are representative of the European American population: implications for pharmacogenetics.

Pharmacogenomics 2005 Jan;6(1):59-63

Washington University School of Medicine, Department of Medicine, St. Louis, MO, USA.

View Article
January 2005

CYP3A5 polymorphism and the ethnic differences in cyclosporine pharmacokinetics in healthy subjects.

Ther Drug Monit 2004 Oct;26(5):524-8

Division of Clinical and Administrative Pharmacy, College of Pharmacy, The University of Iowa, Iowa City, Iowa, USA.

View Article
October 2004

Pharmacogenetics of irinotecan toxicity.

Pharmacogenomics 2004 Oct;5(7):835-43

Washington University, School of Medicine, Division of Oncology, 660 South Euclid Avenue, Campus Box 8069, St Louis, MO 63110, USA.

View Article
October 2004

Pharmacogenomic assessment of carboxylesterases 1 and 2.

Genomics 2004 Oct;84(4):661-8

Department of Medicine, Washington University School of Medicine and the Siteman Cancer Center, St Louis, MO 63110, USA.

View Article
October 2004

ABCG2 pharmacogenetics: ethnic differences in allele frequency and assessment of influence on irinotecan disposition.

Clin Cancer Res 2004 Sep;10(17):5889-94

Department of Medical Oncology, Erasmus University MC-Daniel den Hoed Cancer Center, Rotterdam, The Netherlands.

View Article
September 2004

Pharmacogenetics of tipifarnib (R115777) transport and metabolism in cancer patients.

Invest New Drugs 2004 Aug;22(3):285-9

Clinical Pharmacology Research Core, National Cancer Institute, Bethesda, MD, USA.

View Article
August 2004

Caution with beta1-adrenergic receptor genotyping.

Clin Pharmacol Ther 2004 Aug;76(2):185-6; author reply 186

View Article
August 2004

Frequency of compound genotypes associated with beta-blocker efficacy in congestive heart failure.

Pharmacogenomics 2004 Jul;5(5):553-8

Washington University School of Medicine, Department of Medicine, 660 S Euclid Ave, Campus Box 8069, St Louis, MO 63110-1093, USA.

View Article
July 2004

Single nucleotide polymorphism profiling across the methotrexate pathway in normal subjects and patients with rheumatoid arthritis.

Pharmacogenomics 2004 Jul;5(5):559-69

Department of Medicine, Washington University School of Medicine, St Louis, Missouri 63110, USA. prangana

View Article
July 2004

Diflomotecan pharmacokinetics in relation to ABCG2 421C>A genotype.

Clin Pharmacol Ther 2004 Jul;76(1):38-44

Medical Oncology Clinical Research Unit, National Cancer Institute, Bethesda, MD 20892, USA.

View Article
July 2004

Genotypes associated with myocardial infarction risk are more common in African Americans than in European Americans.

J Am Coll Cardiol 2004 Jul;44(1):165-7

Washington University School of Medicine, Department of Medicine, St. Louis, Missouri 63110-1093, USA.

View Article
July 2004

Application of pharmacogenomics in the individualization of chemotherapy for gastrointestinal malignancies.

Clin Colorectal Cancer 2004 Jun;4 Suppl 1:S43-7

Department of Medicine and the Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO 63110-1093, USA.

View Article
June 2004

Use of pyrosequencing to detect clinically relevant polymorphisms in dihydropyrimidine dehydrogenase.

Clin Chem 2003 Oct;49(10):1661-4

Washington University School of Medicine, Division of Oncology, St. Louis, MO 63110, USA.

View Article
October 2003

Ferredoxin reductase: pharmacogenomic assessment in colorectal cancer.

Cancer Res 2003 Oct;63(19):6170-3

Department of Medicine, Washington University School of Medicine and the Siteman Cancer Center, 660 South Euclid Avenue, St. Louis, MO 63110, USA.

View Article
October 2003

Irinotecan pathway genotype analysis to predict pharmacokinetics.

Clin Cancer Res 2003 Aug;9(9):3246-53

Department of Medical Oncology, Erasmus MC-Daniel den Hoed Cancer Center, 3075 EA Rotterdam, the Netherlands.

View Article
August 2003

Pharmacogenetic analysis of clinically relevant genetic polymorphisms.

Methods Mol Med 2003 ;85:225-37

Washington University School of Medicine, St. Louis, MO, USA.

View Article
June 2003

SNP databases and pharmacogenetics: great start, but a long way to go.

Hum Mutat 2002 Sep;20(3):174-9

Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.

View Article
September 2002

Primary colorectal tumour is not an accurate predictor of thymidylate synthase in lymph node metastasis.

Oncol Rep 2002 Mar-Apr;9(2):231-4

Department of Medicine and Therapeutics, Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UK.

View Article
May 2002